Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.48 SEK | -2.42% | -4.03% | +59.51% |
Mar. 27 | Diamyd Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024 | CI |
Mar. 19 | Diamyd Medical to Raise SEK114 Million Via Share Offering | MT |
Sales 2024 * | 3M 280K | Sales 2025 * | 3M 280K | Capitalization | 1.02B 95.19M |
---|---|---|---|---|---|
Net income 2024 * | -152M -14.19M | Net income 2025 * | -202M -18.86M | EV / Sales 2024 * | 324 x |
Net cash position 2024 * | 49M 4.57M | Net cash position 2025 * | 49M 4.57M | EV / Sales 2025 * | 324 x |
P/E ratio 2024 * |
-6.71
x | P/E ratio 2025 * |
-5.04
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 72.58% |
Latest transcript on Diamyd Medical AB
1 day | -2.42% | ||
1 week | -5.07% | ||
Current month | -28.90% | ||
1 month | -27.82% | ||
3 months | +57.59% | ||
6 months | +30.67% | ||
Current year | +59.51% |
Managers | Title | Age | Since |
---|---|---|---|
Ulf Hannelius
CEO | Chief Executive Officer | 49 | 16-04-09 |
Founder | 83 | 95-12-31 | |
Anna Styrud
DFI | Director of Finance/CFO | 63 | 09-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 83 | 95-12-31 | |
Director/Board Member | 63 | 11-12-31 | |
Director/Board Member | 52 | 21-04-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 10.48 | -2.42% | 69 583 |
24-03-27 | 10.74 | +1.13% | 209,089 |
24-03-26 | 10.62 | -1.67% | 132,329 |
24-03-25 | 10.8 | -1.46% | 254,359 |
24-03-22 | 10.96 | -0.72% | 88,462 |
Delayed Quote Nasdaq Stockholm, March 28, 2024 at 06:02 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+59.51% | 96.01M | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.57% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |